KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $8,991,000 | -54.5% | 119,912 | -54.3% | 0.12% | -48.5% |
Q2 2015 | $19,772,000 | +32.0% | 262,547 | -12.1% | 0.23% | +32.4% |
Q1 2015 | $14,975,000 | +49.1% | 298,599 | +3.1% | 0.18% | +63.0% |
Q4 2014 | $10,043,000 | +207.9% | 289,594 | +190.8% | 0.11% | +200.0% |
Q3 2014 | $3,262,000 | -9.1% | 99,585 | +6.5% | 0.04% | +2.9% |
Q2 2014 | $3,587,000 | +59.5% | 93,490 | +65.3% | 0.04% | +16.7% |
Q1 2014 | $2,249,000 | +24.9% | 56,570 | +17.3% | 0.03% | +25.0% |
Q4 2013 | $1,801,000 | – | 48,220 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |